Familial hyperchylomicronemia syndrome is a rare autosomal recessive metabolic disorder caused by the mutation in lipoprotein lipase. It correlates with significant morbidity and distress amongst the patients. This article describes the background, pathophysiology, history, and physical and evaluation of type 1 familial hyperlipidemia. It also gives us insight into the management of type-1 hyperlipidemia.

**Objectives:**
- Identify the etiology and epidemiology of familial hyperchylomicronemia syndrome.
- Review the evaluation of familial hyperchylomicronemia syndrome.
- Outline the treatment and management options available for familial hyperchylomicronemia syndrome.
- Describe some interprofessional team strategies for improving care coordination and communication to advance familial hyperchylomicronemia syndrome and improve outcomes.